Deramaxx Approved For Post-Op Dental Pain In Dogs
December 9, 2011
Novartis Animal Health U.S. Inc.’s Deramaxx (deracoxib) received U.S. Food and Drug Administration approval for control of postoperative pain and inflammation associated with dental surgery in dogs, the company reported today. Deramaxx was previously approved for the control and inflammation associated with canine osteoarthritis, and a clinical field study of 62 dogs showed the product… Continue reading...